AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01766752 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GlucoTab System
Description: Tablet based workflow and decision support system with incorporated software algorithm (GlucoTab) used for glycaemic management in non-critically ill patients with type 2 diabetes at the general ward
Study NCT05285995 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Intervention
Description: Before the operation, subjects were asked to choose their favorite music to listen so as to reduce the anxiety before the operation and before the induction of anesthesia.
Study NCT05285995 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The animation intervention
Description: Before surgery, subjects were asked to choose their favorite cartoons to watch to reduce anxiety before surgery and induction of anesthesia.
Study NCT02807012 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nursing educational intervention
Description: The nursing educational intervention by home visits will consist in three home visits by nurses until 14, 21 and 30 days after discharge to the intervention group. The nurses will give verbal information to family caregiver related to the care of elderly with stroke based on protocol with orientation related: information about stroke; emotional support; how to access health services; nutrition; airway; hygiene; positioning and transferring; prevent falls; dress/undress; medications; physiological eliminations; skin care. Furthermore, nurses will give some printed materials that contain orientations related to the care.~The control group could have ou not the usual care guidelines provide by health services that have access.
Study NCT03067688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temisartan+Amlodipine+Rosuvastatin (Combination drug)
Description: PO, Once daily(QD), 8weeks
Study NCT03067688 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Temisartan+Amlodipine
Description: PO, Once daily(QD), 8weeks
Study NCT03067688 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Temisartan+Rosuvastatin
Description: PO, Once daily(QD), 8weeks
Study NCT03734146 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: 180 minutes of moderate-vigorous intensity aerobic exercise per week
Study NCT03734146 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance Exercise
Description: 180 minutes of resistance exercise per week
Study NCT03734146 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise
Description: 180 minutes of exercise per week with 90 minutes per week coming from moderate-vigorous intensity aerobic exercise and 90 minutes per week coming from resistance exercise
Study NCT03284489 — intervention group
Intervention type: OTHER
Intervention: Collection of medical datas from ICU patients
Description: Collection of medical datas from ICU patients with pancreatitis on a secured electronic database
Study NCT04741815 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Forced Air Warming
Description: It consists of the WarmAir® unit and FilteredFlo® blankets. FilteredFlo® blankets are a cover designed to cover the entire body and extremities with air channels that provide the appropriate distribution of patient warm. The WarmAir® warming device connected to the shroud via a pipe; it has three temperature settings, 32.2 C, 37.8 C, and 43.3 C.
Study NCT04741815 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Peripheral Carbon Fiber Warming
Description: It was developed by the researcher. Designed as gloves and socks, these warming materials have three layers. The first layer in contact with the patient and the third layer in contact with the external environment is a thermal material to maintain body temperature. The second floor consists of a USB-connected carbon fiber warmer and foil.
Study NCT02253147 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TEOSYAL® RHA Ultra Deep
Description: A sterile, biodegradable, biocompatible, viscoelastic, clear, colorless, homogenized gel implant. It consists of cross-linked hyaluronic acid produced by fermentation of Streptococcus equi bacteria, formulated to a concentration of 23 mg/mL and 0.3% w/w lidocaine in a physiologic buffer. It is supplied in individual treatment syringes with 27Gauge ½ disposable sterile needles.
Study NCT01064258 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CPAP
Description: CPAP at 4 cm H2O
Study NCT01064258 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: autoCPAP
Description: autoCPAP working between 4 and 15 cm H2O
Study NCT01640769 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Image guided delivery of cardiac pacing leads.
Description: Patients will be blindly randomized to image guided delivery of pacing leads during cardiac resynchronization therapy device implantation (study arm).
Study NCT01640769 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Standard delivery of cardiac pacing leads.
Description: Patients will be blindly randomized to standard implantation of pacing leads during cardiac resynchronization therapy device implantation (control arm).
Study NCT01871181 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ilioinguinal block
Description: 0.25% bupivacaine will be administered on a mg/kg basis
Study NCT01871181 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local infiltration
Description: Surgeon will infiltrate incision area with local anesthetic before closure.
Study NCT01692249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: immediate spa therapy
Description: , with 18 days of therapy over 3 weeks; The standardized shoulder therapy program was designed by experienced spa therapy physicians. Spa mineral water and treatments are approved and controlled by the French authorities. Spa treatment included: bubble buses at 36°C for 15 minutes, applications of mineral matured mud at 45°C to the shoulder for 20 minutes, mineral hydrojet sessions at 39°C for 7 minutes and general mobilization in a collective mineral water pool at 35°C for 20 minutes supervised by a registered physiotherapist.
Study NCT03387228 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain education
Description: Pain education intervention we plan to use is based on Explain Pain developed by Moseley and Butler in 2003. The pain education handout and materials produced in Nepali will be proof-read and pre-tested in 5 - 10 Nepalese with LBP as needed, and corrected, if necessary.~Dosage: A single (approximately) one hour pain education will be delivered to the PEG.~Home advice: A printed handout of the pain education material will be provided only to the study participants in the PEG. Participants will be advised to read them (or have family members read them), followed by walking for 30 minutes.
Study NCT03387228 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: The control participants will receive physiotherapy care based on the recent clinical practice guidelines. This control group intervention will comprise of: (1) education (advice to remain active); (2) massage to back; (3) superficial heat; and (4) static cycling or (treadmill) walking with the aim to promote physical activity. Although superficial heat is recommended in the acute/subacute LBP, we included this as a common treatment for all types of LBP including chronic LBP, which could be a part of self-management.~Duration of treatment: 1 hour. Home advice: Participants will be advised to self-manage their back pain based on the information provided. Home exercise leaflet with emphasis on the value of exercise to increase strength and endurance, followed by a 30 minutes walking.
Study NCT03596606 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Manual Treatment
Description: The manual treatment will be adapted to each patient at the discretion of the therapist, being able to select all or part of the following osteopathic techniques in each session.~* Soft tissue techniques.~* Articulatory techniques applied at cervical level~* Osteopathic manipulation techniques applied at the affected jaw/s.~* Functional Indirect technique at the level of the affected jaw/s: For Type I or II diagnosis.
Study NCT03596606 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual Treatment
Description: The manual treatment will be adapted to each patient at the discretion of the therapist, being able to select all or part of the following osteopathic techniques in each session.~* Soft tissue techniques.~* Articulatory techniques applied at cervical level~* Osteopathic manipulation techniques applied at the affected jaw/s.~* Functional Indirect technique at the level of the affected jaw/s: For Type I or II diagnosis.
Study NCT03596606 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Myofunctional Motor control exercises
Description: The protocol is a set of 8 exercises to improve the execution of the function in the stomatognathic and cervical area.~The therapist explains the objectives of the exercises and the patient performs it after each session and at home three times a day.~The first day before performing the myofunctional exercises, will be an explanatory talk prior to the exercises in order to educate the patient. The second day, before doing the exercises, will review the concept of memory of pain and the benefits of doing the exercises
Study NCT02683252 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: T1 mapping and MR perfusion acquisition
Description: One T1 mapping acquisition with variable flip angles will be performed before contrast injection. One perfusion 3D FSPGR sequence will be acquired after contrast injection
Study NCT00851916 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: CyberKnife Radiosurgery
Description: CyberKnife Radiosurgery
Study NCT02305381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: semaglutide
Description: Injected subcutaneously (s.c. under the skin) once-weekly. As add-on to the pre-trial background medication.
Study NCT02305381 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Injected subcutaneously (s.c. under the skin) once-weekly. As add-on to the pre-trial background medication.
Study NCT03164941 — intervention group
Intervention type: PROCEDURE
Intervention: Selective Laser Trabeculoplasty
Description: Laser treatment for glaucoma.
Study NCT02381743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group 2 intervention daily SMS bullet point
Description: Group 2 subjects receive a daily SMS bullet point, summarizing a key clinical point pertinent to the CBPA's daily work.
Study NCT02381743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group 3 intervention daily SMS bullet point
Description: Group 3 subjects receive a c phrased as a multiple choice question. The content mirrors that of group 2, but is presented as a question to render it interactive
Study NCT02341287 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Warming hydrogel glove
Description: Subjects wore the warming hydrogel glove in either the first or second two-week period.
Study NCT02341287 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Warming hydrogel glove
Description: Subjects wore the warming hydrogel glove in either the first or second two-week period.
Study NCT02341287 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Non-thermal glove
Description: Subjects wore the non-thermal glove in either the first or second two-week period.
Study NCT02341287 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Non-thermal glove
Description: Subjects wore the non-thermal glove in either the first or second two-week period.
Study NCT03615521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hotpack
Description: Hotpack applied 20 minutes for knee 3 session for 6 weeks
Study NCT03615521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: Ultrasound applied 10 minutes for knee 3 session for 6 weeks
Study NCT03615521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combine Exercise
Description: Proprioceptive Neuromusculer Facilitation Technique İnclude eccentric and concentric contractions 3 session for 6 week
Study NCT03615521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Repeated Contraction Exercise
Description: Proprioceptive Neuromusculer Facilitation Technique include concentric contractions 3 session for 6 week
Study NCT03615521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standart Exercise Therapy
Description: Quadriceps, hamstring and hip muscle strength exercise. Hamstring stretch exercise.~3 session for 6 week
Study NCT03841123 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Counseling
Description: The intervention will consist of an individualized, face-to-face, 20 to 30 minute counseling session to mothers by trained health workers who will address healthy eating practices during the first two years of life. A printed, colorful and illustrated material will be used to assist mothers in appropriate food choices, mainly to avoid the introduction of sugar and ultra-processed foods. In addition, they will receive a booklet which addresses the Ten Steps of Healthy Feeding for children from Birth to Two years of life. The research team will focus on Step2: Do not give added sugar or foods with added sugar, and Step8:Do not offer ultra-processed foods as candies and soft drinks. To reinforce the intervention, mothers will receive telephone calls up to the infant reach six months.
Study NCT04033172 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib Plus Fulvestrant
Description: Pyrotinib: 400 mg/d, q.d., p.o. A course of treatment need 28 days. Fulvestrant: 500 mg/m2 q.d. i.m. A course of treatment need 28 day. First course needs extra dose of fulvestrant 500 mg/m2 q.d. i.m. on day 15.
Study NCT00823420 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: prematuration culture
Description: The aneuploidy rate and the developmental potential of embryos obtained from PDE3 inhibitor-treated oocytes (a prolonged IVM (PMC)) in comparison to conventional IVM will be analysed. It is intended to assess the nuclear and cytogenetic constitution of the obtained embryos.
Study NCT00553202 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-thymocyte globulin
Description: Given IV
Study NCT00553202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: busulfan
Description: Given IV
Study NCT00553202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV
Study NCT00553202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclosporine
Description: Given IV or orally
Study NCT00553202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methotrexate
Description: Given IV
Study NCT00553202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylprednisolone
Description: Given IV
Study NCT00553202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tacrolimus
Description: Given IV
Study NCT00553202 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT00553202 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT00553202 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: allogeneic bone marrow transplantation
Description: allogeneic bone marrow transplantation
Study NCT00553202 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: allogeneic hematopoietic stem cell transplantation
Description: Undergo allogeneic hematopoietic SCT
Study NCT00077636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Copegus
Description: 400mg po bid for 16 weeks
Study NCT00077636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Copegus
Description: 400mg po bid for 24 weeks
Study NCT00077636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a [Pegasys]
Description: 180 micrograms sc weekly for 16 weeks
Study NCT00077636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a [Pegasys]
Description: 180 micrograms sc weekly for 24 weeks
Study NCT01923896 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention
Description: Behavioral intervention targeting severe feeding disorders involves the combination of escape extinction and antecedent manipulation of food presentation to lessen the aversive quality of the meal. This allows treatment to address the consequences maintaining food refusal in the least restrictive environment while ameliorating possible side effects associated with extinction procedures.
Study NCT01923896 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral Intervention
Description: Behavioral intervention targeting severe feeding disorders involves the combination of escape extinction and antecedent manipulation of food presentation to lessen the aversive quality of the meal. This allows treatment to address the consequences maintaining food refusal in the least restrictive environment while ameliorating possible side effects associated with extinction procedures.
Study NCT01923896 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: d-cycloserine (DCS)
Study NCT01923896 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: lactose powder
Study NCT02679521 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ESWT
Description: Radial extracorporeal shock wave therapy (rESWT) was performed by the principal investigator with a Swiss DolorClast device (EMS Electro Medical Systems Corporation; Dallas, Texas, USA).~The Swiss DolorClast device obtained Pre-Market Approval (PMA) by FDA as Class III orthopedic lithotripsy device to treat heel pain associated with chronic proximal plantar fasciitis on May 8, 2007 (PMA # P050004), and was re-classified as Class III Generator, Shock Wave, For Pain Relief (Product Code NBN) in the Spring 2009. The present study started on October 3, 2007.~Each patient received two sessions of rESWT one week apart, with 2,000 impulses per session (air pressure of the device set at 3.5 bar; impulses applied with the 15 mm applicator at frequency of 8 Hz).
Study NCT02679521 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo treatment was performed identically as rESWT but with a clasp on the heel that prevented transmission of the impulses from the applicator to the skin at the treatment site.
Study NCT02714868 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project TEAM
Description: Project TEAM is a manualized, group-based intervention designed to be co-facilitated by an experienced leader with a disability (disability advocate) and a licensed service provider (such as an occupational therapist, social worker, or educator). Project TEAM includes eight group sessions and two experiential learning field trips for each participant. Weekly phone calls with peer mentors with disabilities support achievement of each participant's personal activity goal.
Study NCT02714868 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Matched Comparison
Description: Participants set goal to try a new activity in the community
Study NCT02040272 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: (Extended) pleurectomy decortication
Study NCT04389333 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: non-contact magnetically-controlled capsule endoscopy
Description: The novel non-contact magnetically-controlled capsule endoscopy (MCE) system (Ankon Technologies, Wuhan, China) (Figure 1) added a remote control workstation and an audio-visual exchange system to the original well-establish MCE system, which consisted of a robotic magnetic arm, a workstation (currently bypassed) and a capsule endoscope.
Study NCT04389333 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: non-contact magnetically-controlled capsule endoscopy
Description: The novel non-contact magnetically-controlled capsule endoscopy (MCE) system (Ankon Technologies, Wuhan, China) (Figure 1) added a remote control workstation and an audio-visual exchange system to the original well-establish MCE system, which consisted of a robotic magnetic arm, a workstation (currently bypassed) and a capsule endoscope.
Study NCT02010697 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Messages targeting nonsmokers
Study NCT02010697 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Messages targeting smokers
Study NCT01623843 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arthroscopic Lavage
Description: Lavage: inflammation debris caused from continual friction in the hip is washed out.
Study NCT01623843 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic Osteochondroplasty
Description: Osteochondroplasty: reshaping the hip ball and socket (osteoplasty or rim trimming).
Study NCT04123106 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ESP block
Description: ESP block bilaterally performed at the level of the surgical site prior to surgery.
Study NCT04123106 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wound infiltration
Description: Wound infiltration performed at the surgical site at the end of surgery.
Study NCT04498689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: Patients firstly receive camrelizumab 200 mg per time (iv, no less than 20 minutes and no more than 60 minutes, rinse time included) on Day 1 and 15 for 3 weeks, followed by one week without treatment. Treatment repeats every 4 weeks until the disease recurrence, unacceptable toxicity, death or begin a novel therapeutic.